Vendor, Washington, DC
Albert B. Sabin Vaccine Institute, Inc. (The)
UEI H5E8NU6N2HZ5, CAGE 5MPW2
3 awards and $321,218,266 obligated between January 10, 2025 and August 19, 2026, 67% under full and open competition, against 1.7 offers on average where reported. 5 of the awards trace back to a SAM.gov solicitation on this site.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $321,218,266 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $321,218,266 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Full and Open Competition After Exclusion of Sources | 1 |
| Definitive Contract | 3 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP)
Office of Assistant Secretary for Preparedness and Response, Barda - Aspr / Daappo / Barda DCMA
Award noticeNAICS 541714District of Columbia75A50125R00006Awarded to Albert B. Sabin Vaccine Institute, Inc. (The) for $1,042,099,118
Posted May 75 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50126C00001Definitive Contract, May 5, 2026, Full and Open Competition, 1 offersSolicitation | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (Smart-Prep)NAICS 541714, PSC 6505 | $263,613,186 |
| 75A50123C00010Definitive Contract, January 10, 2025, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | The Purpose of This No Cost Modification Is to Donate 188 Vials of Sudv Clinical Trial Material for Three Nonclinical Studies as Follows: 1.NAICS 541714, PSC AN42 | $57,605,080 |
| 75A50119C00055Definitive Contract, May 6, 2025, Full and Open Competition After Exclusion of Sources, 3 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Advance the Development of Monovalent Vaccines for Prevention of Marburg Virus (Marv) and Sudan Ebolavirus (Sudv) Disease.NAICS 541714, PSC AN73 | $0 |
- Places of performance
- District of Columbia
- Product and service codes
- 6505 Drugs and BiologicalsAN42 Health R&D Services; Health Care - Other; Applied ResearchAN73 N – Health R&D Services
- Transactions
- 9 across 3 awards